The Treatment of Melanoma With Emerging Targeted Therapies

Publication
Article
Special ReportsMelanoma (Issue 1)
Volume 1
Issue 1

Georgina Long, BSc, PhD, MBBS, FRACP, medical oncologist, translational researcher, Melanoma Institute Australia, The University of Sydney, discusses the treatment of melanoma with emerging targeted therapies.

Articles in this issue
Two BRAF Fusions Discovered in Some Pan-Negative Melanomas
Two BRAF Fusions Discovered in Some Pan-Negative Melanomas
Understanding the Biologic Pathways in Basal Cell Carcinoma
Understanding the Biologic Pathways in Basal Cell Carcinoma
Advances in Metastatic Melanoma
Advances in Metastatic Melanoma
Targeted and Immunotherapy in Metastatic Melanoma: An Interview With Jeffrey S Weber, MD, PhD
Targeted and Immunotherapy in Metastatic Melanoma: An Interview With Jeffrey S Weber, MD, PhD
Targeted Therapies in Basal Cell Carcinoma
Targeted Therapies in Basal Cell Carcinoma
The Outlook for BRAF Inhibitors in Melanoma
The Outlook for BRAF Inhibitors in Melanoma
Combinations and Immunotherapies Detailed at Society for Melanoma Research 10th International Meeting
Combinations and Immunotherapies Detailed at Society for Melanoma Research 10th International Meeting
The Treatment of Melanoma With Emerging Targeted Therapies
The Treatment of Melanoma With Emerging Targeted Therapies
The Challenges of Treating Metastatic Melanoma With BRAF Inhibitor Monotherapy
The Challenges of Treating Metastatic Melanoma With BRAF Inhibitor Monotherapy

Newsletter

Stay up to date on practice-changing data in community practice.

Subscribe Now!
Recent Videos
Related Content
NEO-MEL-T Study: Mooradian Explores TIM-3/PD-1 in Resectable Melanoma

NEO-MEL-T Study: Mooradian Explores TIM-3/PD-1 in Resectable Melanoma

Sabrina Serani
June 24th 2025
Article

Read More

Advancing Melanoma Treatment: Hamid on Lifileucel's Role

Advancing Melanoma Treatment: Hamid on Lifileucel's Role

Jordyn Sava;Omid Hamid, MD
July 15th 2024
Podcast

In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma.

Listen

Navigating the Treatment Landscape in Non–Clear Cell Renal Cell Carcinoma

Navigating the Treatment Landscape in Non–Clear Cell Renal Cell Carcinoma

Charles B. Nguyen, MD
June 23rd 2025
Article

Read More

Understanding and Treating Mucosal Melanoma

Understanding and Treating Mucosal Melanoma

Nichole Tucker;Richard Carvajal, MD
April 14th 2023
Podcast

In season 4, episode 4 of Targeted Talks, Richard D. Carvajal, MD, discusses mucosal melanoma and treatment options for the disease.

Listen

Defining the Role of Consolidative Thoracic Radiotherapy Post Immunotherapy in ES-SCLC

Defining the Role of Consolidative Thoracic Radiotherapy Post Immunotherapy in ES-SCLC

Igor Randulfe, MD;Federico Monaca, MD
June 21st 2025
Article

Explore the role of consolidative thoracic radiotherapy in enhancing survival for extensive-stage small cell lung cancer post-chemoimmunotherapy.

Read More

Pembrolizumab and Chemoradiation Deliver Durable Responses in Stage III NSCLC

Pembrolizumab and Chemoradiation Deliver Durable Responses in Stage III NSCLC

Kristi Rosa
June 21st 2025
Article

Pembrolizumab combined with chemoradiation shows promising long-term efficacy and safety in treating advanced non-small cell lung cancer.

Read More